RhumbLine Advisers
OM icon

RhumbLine Advisers’s Outset Medical OM Stock Holding History

RhumbLine Advisers’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36K Sell
8,327
-13,257
-61% -$58K ﹤0.01% 3741
2026
Q1 		$82.9K Buy
21,584
+658
+3% +$2.7K ﹤0.01% 3475
2025
Q4 		$77.6K Sell
20,926
-3,390
-14% -$29.1K ﹤0.01% 3551
2025
Q3 		$343K Sell
24,316
-1,659
-6% -$25.9K ﹤0.01% 2908
2025
Q2 		$499K Buy
+25,975
New +$405K ﹤0.01% 2685
2024
Q3 		– Sell
-1,495
Closed -$86.3K – 4290
2024
Q2 		$86.3K Sell
1,495
-3,113
-68% -$153K ﹤0.01% 3550
2024
Q1 		$153K Buy
4,608
+178
+4% +$9.01K ﹤0.01% 3290
2023
Q4 		$359K Sell
4,430
-49
-1% -$3.99K ﹤0.01% 2862
2023
Q3 		$731K Sell
4,479
-5
-0.1% -$1.18K ﹤0.01% 2380
2023
Q2 		$1.47M Buy
4,484
+147
+3% +$44.8K ﹤0.01% 2082
2023
Q1 		$1.2M Buy
4,337
+161
+4% +$59.1K ﹤0.01% 2045
2022
Q4 		$1.62M Buy
4,176
+148
+4% +$41.7K ﹤0.01% 1897
2022
Q3 		$963K Buy
4,028
+328
+9% +$87.8K ﹤0.01% 2153
2022
Q2 		$825K Buy
3,700
+424
+13% +$182K ﹤0.01% 2228
2022
Q1 		$2.23M Buy
3,276
+133
+4% +$80K ﹤0.01% 1757
2021
Q4 		$2.17M Buy
3,143
+60
+2% +$44.4K ﹤0.01% 1832
2021
Q3 		$2.29M Buy
3,083
+132
+4% +$89.9K ﹤0.01% 1831
2021
Q2 		$2.21M Buy
2,951
+2,326
+372% +$1.78M ﹤0.01% 1903
2021
Q1 		$510K Sell
625
-8
-1% -$6.17K ﹤0.01% 2485
2020
Q4 		$540K Buy
+633
New +$488K ﹤0.01% 2409

Other funds holding OM

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RhumbLine Advisers's OM Position: Q2 2026 in Review

RhumbLine Advisers reduced its Outset Medical (OM) stake by 61% in Q2 2026, selling an estimated $58K and leaving 8,327 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #3741.

RhumbLine Advisers first reported a position in OM in Q4 2020 and has held it in 20 quarters since. The position peaked at $2.29M in Q3 2021. 66 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • RhumbLine Advisers held 8,327 shares of Outset Medical worth $36K as of Q2 2026.
  • RhumbLine Advisers sold 13,257 Outset Medical shares in Q2 2026, an estimated $58K.
  • Outset Medical made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3741 holding.
  • RhumbLine Advisers first reported a position in Outset Medical in Q4 2020 and has held it in 20 quarters since.
  • RhumbLine Advisers's Outset Medical position peaked at $2.29M in Q3 2021.
  • 66 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.